Gly MCA
Chemical Name: N-[(3α,5β,6β,7β)-3,6,7-Trihydroxy-24-oxocholan-24-yl]glycine
Biological Activity
Gly MCA is a farnesoid X receptor (FXR) antagonist. Accumulates in ileum and inhibits FXR signaling exclusively in intestine. Inhibits or reverses high-fat diet-induced and genetic obesity, insulin resistance and hepatic steatosis in mice. Reduces obesity and metabolic syndrome in obese mice. Orally bioavailable.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Complete Your Research
Background References
-
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction.
Jiang et al.
Nat.Commun., 2015;6:10166 -
Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism.
Wahlström et al.
Cell Metab., 2016;24:41 -
Gut-brain cross-talk in metabolic control.
Clemmensen et al.
Cell, 2017;168:758
Product Datasheets
Reconstitution Calculator
Molarity Calculator
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for Gly MCA
There are currently no reviews for this product. Be the first to review Gly MCA and earn rewards!
Have you used Gly MCA?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image